Your session is about to expire
← Back to Search
Propofol slow administration for Low Blood Pressure
Study Summary
This trial is testing whether giving propofol more slowly causes fewer problems with blood pressure than the standard way it's given.
- Low Blood Pressure
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research study allow for individuals over 35 years old to participate?
"This study is currently looking for individuals that fall between 18 and 80 years old."
What is the long-term outlook for people who receive Propofol slowly?
"There is some efficacy data and multiple rounds of safety data, meaning that Propofol slow administration can be classified as a 3 on the Power team's 1-3 scale."
What is the maximum patient quota for this research project?
"That is correct. According to the information available on clinicaltrials.gov, this trial is still recruiting patients. The study was originally posted on August 11th, 2022 and was last edited on November 2nd, 2022. They are hoping to enrol 100 patients at a single site."
Are there any unfilled positions in this trial that patients could sign up for?
"From what is available on clinicaltrials.gov, this trial is currently looking for participants. The 8/11/2022 date refers to when the study was originally posted, with the 11/2/2022 date being when the listing was last edited."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger